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Spatial normalization is a prerequisite step for analyzing positron emission tomography
(PET) images both by using volume-of-interest (VOI) template and voxel-based analysis.
Magnetic resonance (MR) or ligand-specific PET templates are currently used for spatial nor-
malization of PET images. We used computed tomography (CT) images acquired with PET/
CT scanner for the spatial normalization for [18F]-N-3-fluoropropyl-2-betacarboxymethoxy-3-
beta-(4-iodophenyl) nortropane (FP-CIT) PET images and compared target-to-cerebellar
standardized uptake value ratio (SUVR) values with those obtained fromMR- or PET-guided
spatial normalization method in healthy controls and patients with Parkinson’s disease (PD).
Methods
We included 71 healthy controls and 56 patients with PD who underwent [18F]-FP-CIT PET
scans with a PET/CT scanner and T1-weighted MR scans. Spatial normalization of MR
images was done with a conventional spatial normalization tool (cvMR) and with DARTEL
toolbox (dtMR) in statistical parametric mapping software. The CT images were modified in
two ways, skull-stripping (ssCT) and intensity transformation (itCT). We normalized PET
images with cvMR-, dtMR-, ssCT-, itCT-, and PET-guided methods by using specific tem-
plates for each modality and measured striatal SUVR with a VOI template. The SUVR val-
ues measured with FreeSurfer-generated VOIs (FSVOI) overlaid on original PET images
were also used as a gold standard for comparison.
Results
The SUVR values derived from all four structure-guided spatial normalization methods
were highly correlated with those measured with FSVOI (P < 0.0001). Putaminal SUVR
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values were highly effective for discriminating PD patients from controls. However, the
PET-guided method excessively overestimated striatal SUVR values in the PD patients by
more than 30% in caudate and putamen, and thereby spoiled the linearity between the stria-
tal SUVR values in all subjects and showed lower disease discrimination ability. Two CT-
guided methods showed comparable capability with the MR-guided methods in separating
PD patients from controls and showed better correlation between putaminal SUVR values
and the parkinsonian motor severity than the PET-guided method.
Conclusion
CT-guided spatial normalization methods provided reliable striatal SUVR values compara-
ble to those obtained with MR-guided methods. CT-guided methods can be useful for ana-
lyzing dopamine transporter PET images when MR images are unavailable.
Introduction
Dopamine transporter positron emission tomography (PET) is now popularly used in clinics
to visualize the integrity of presynaptic dopaminergic nerve terminals, and a quantitation of
striatal binding in PET images is important for detecting preclinical stage, monitoring disease
progression, and evaluating responses to disease modifying treatment in Parkinson’s disease
(PD) [1]. For the quantification of striatal binding, manually drawn striatal region-of-interest
(ROI) directly on individual PET image had been used; however, this conventional ROI
method is time-consuming and vulnerable to inter- and intra-operator variability [2, 3]. More-
over, as the radioligand uptake in the posterior putamen is markedly reduced even in the early
stage of PD [4], it is frequently difficult to trace the putaminal margins without reference to
magnetic resonance (MR) images. Therefore, a striatal volume-of-interest (VOI) template
overlaid on spatially normalized PET images is required to achieve objective, user-independent
quantification of striatal binding.
For spatial normalization, PET images can be directly normalized to ligand-specific PET tem-
plate (PET-guided method), or indirectly to MR template by applying transformation parame-
ters normalizing MR images to coregistered PET images (MR-guided method). While the spatial
normalization of dopamine transporter PET images using ligand-specific PET template can be
readily performed, it frequently causes errors in PD patients due to markedly reduced uptake in
the posterior putamen. Thus, some PET studies have used summed PET images of entire or ear-
lier time frames of dynamic PET for spatial normalization [5, 6]. The MR-guided spatial normal-
ization method is generally more accurate than the PET-guided method and works
independently from receptor density [7, 8]. Another approach based on structural image for spa-
tial normalization is the computed tomography (CT)-guided method [9, 10]. The PET/CT scan-
ners are now widely used, and structural CT images always accompany PET images for the
attenuation correction. These CT images can be used for spatial normalization.
Spatial normalization of CT images is difficult due to great differences in intensities of the
skull, brain tissue, and air. Thus, spatial normalization is mainly driven by the skull which
shows extremely high intensity [9]. For better spatial normalization, Rorden and colleagues
developed a CT-guided spatial normalization method by using intensity-transformed CT
(itCT) images to reduce intensity contrast between the skull and brain tissue [9]. Skull-strip-
ping to remove the skull and surrounding soft tissue is also helpful for reducing errors in the
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spatial normalization of CT images, as well as MR images [9–13], but there was no reliable
method for skull-stripping of CT images.
We recently developed fully automated skull-stripping method for CT images based on tis-
sue probabilistic templates, and showed the feasibility of CT-guided spatial normalization for
[18F]-fluorodeoxyglucose (FDG) PET imaging [14]. In this study, we applied our CT-guided
spatial normalization technique for the spatial normalization of [18F]-N-3–fluoropropyl-2-b-
carboxymethoxy-3-b-(4-iodophenyl) nortropane (FP-CIT) PET images in PD patients and
sought to determine its feasibility by comparing the striatal binding derived from the itCT-,
PET-, and two MR-guided spatial normalization methods.
Materials and Methods
Subjects
We included 56 consecutive PD patients (M: F = 25: 31, mean age = 61.1 ± 12.4 years) who met
the UK brain bank criteria for the clinical diagnosis of PD [15] and who underwent [18F]-
FP-CIT PET and brain MRI scans for diagnostic work-up over a two year period beginning in
May 2011. In 56 PD patients, 39 patients had never been treated for PD, and the remaining 17
patients were on anti-parkinsonian medications. Right side limbs were clinically more affected
in 22 patients, while the remaining 34 patients were affected more on the left side. The mean
disease duration was 32.1 ± 33.3 months; the mean unified Parkinson’s disease rating scale
(UPDRS) motor score was 28.0 ± 8.1; and the mean Hoen & Yahr stage was 2.3 ± 0.3. We also
included 71 age-matched healthy controls (M: F = 32: 39, mean age = 59.7 ± 10.3 years) who
had no history of neurological illness and no abnormal sign on neurological examination. The
mean ages of the healthy controls and PD patients were not different. This study was approved
by Institutional Review Board (IRB) of Gangnam Severance Hospital and written informed
consent was obtained from all healthy control subjects. As the PET and MR images of the PD
patients were obtained during the process of diagnostic work-up at a tertiary hospital, the IRB
approved for the use of their image data and minimal clinical information without the need to
obtain consent due to the retrospective nature of the study.
Acquisition of PET and MR images
We acquired brain CT and [18F]-FP-CIT PET scans using a Biograph 40 TruePoint PET/CT
scanner (Siemens Medical Solutions; Malvern, PA, USA). At 3 hours after the intravenous injec-
tion of 214.4 ± 35.4 MBq (212.1 ± 31.2 MBq for healthy controls and 217.4 ± 40.2 MBq for PD
patients) of [18F]-FP-CIT, brain CT scans (120 keV, 180 mAs, and 2 mm of slice thickness) were
acquired for attenuation correction, followed by 10 minutes of [18F]-FP-CIT emission PET scan.
A head holder was applied to minimize head motion during the scan. 3D CT and PET images
were reconstructed with a 512 × 512 × 110 matrix using ordered-subsets expectation maximiza-
tion (OSEM) algorithm (iteration = 6 and subset = 16). The voxel size was 0.668 × 0.668 × 2
mm. In all subjects, axial T1-weighted brain MR images were also obtained with 3D-spoiled gra-
dient-recalled sequences (3D-SPGR sequences; repetition time = 6.8 ms, echo time = 1.6 to 11.0
ms, flip angle = 20°, 512 × 512 matrix, voxel spacing 0.469 × 0.469 × 1 mm) in 3.0 Tesla scanner
(Signa EXCITE, GEMedical Systems, Milwaukee, WI).
Image processing
We used statistical parametric mapping 8 software (SPM8; Wellcome Trust Centre for Neuro-
imaging, London, UK) implemented in MATLAB 7.1 (MathWorks, Natick, MA) for coregis-
tration and spatial normalization of images and voxel-based comparison. We also used in-
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house MATLAB programs for simple arithmetic operation of images and measuring regional
uptake values.
a) Creation of CT templates. Using image data from 71 healthy controls, we created two
types of CT templates for spatial normalization; skull-stripped CT (ssCT) template [14] and an
intensity-transformed CT (itCT) template [9].
For creation of the ssCT template, the intensity of CT images was first linearly transformed
by adding minimum voxel values to eliminate negative voxel values. The skull-stripped MR
images were obtained by merging the gray and white matter segments of inhomogeneity-cor-
rected T1-weighted MR images (Fig 1a–1c) and normalized to the skull-stripped Montreal
Neurological Institute (MNI) 152 MR template to derive spatial normalization parameters for
MR images (Fig 1d). Probabilistic maps for whole brain and cerebrospinal fluid (CSF) were cre-
ated by averaging the spatially normalized masks of each MR segment (Fig 1e and 1f). Also, the
probabilistic map for skull was created with the spatially normalized masks of skull segments
of CT images (Fig 1g–1j). The CT images coregistered to individual MR images were spatially
normalized with the spatial normalization parameters for MR images (Fig 1g–1k), and we cre-
ated a temporary whole CT template and a scalp-stripping mask, including skull, whole brain,
Fig 1. Image processing steps for acquiring skull-stripped CT (ssCT) and intensity-transformed CT (itCT) templates. (a) Inhomogeneity correction
and segmentation of MR, (b) creation of whole brain and CSFmasks, (c) skull-stripping of inhomogeneity-corrected MR, (d) spatial normalization of skull-
stripped MR to MNI template for skull-stripped MR, (e) spatial normalization of masks by applying normalization parameter, (f) creation of probabilistic maps
for whole brain and CSF by averaging tissue masks, (g) coregistration of CT to inhomogeneity-corrected MR, (h) creation of skull mask, (i) spatial
normalization of skull mask, (j) creation of probabilistic map for skull, (k) spatial normalization of coregistered CT, (l) creation of whole CT template by
averaging, (m) creation of template mask for scalp-stripping, (n) spatial normalization of CT to whole CT template, (o) inverse normalization of template mask
for scalp-stripping to create individual mask for scalp-stripping, (p) creation of scalp-stripped CT by applying mask, (q) segmentation of scalp-stripped CT into
three tissue type by using probabilistic maps, (r) creation of ssCT by applying mask for whole brain segment, (s) coregistration of ssCT to MR by applying
parameter coregistering original CT to MR, (t) spatial normalization of coregistered ssCT, (u) creation of ssCT template by averaging, (v) intensity
transformation of original CT, (w) coregistration of itCT to MR, (x) spatial normalization of coregistered itCT, (y) creation of itCT template by averaging, and (z)
spatial normalization of individual ssCT and itCT to specific CT templates. The processing steps inside the red (ssCT) and blue (itCT) dashed lines represent
the image processing steps required for the spatial normalization of CT images with created CT templates.
doi:10.1371/journal.pone.0132585.g001
CT-Guided Spatial Normalization of Dopamine Transporter PET
PLOSONE | DOI:10.1371/journal.pone.0132585 July 6, 2015 4 / 18
CSF and soft tissue below the convexity of skull (Fig 1l and 1m). All CT images were spatially
normalized to this whole CT template (Fig 1n) and scalp-stripped by applying inversely nor-
malized scalp-stripping mask images (Fig 1o and 1p). Scalp-stripped CT images were seg-
mented into skull, whole brain, and CSF using the probabilistic maps for each tissue type in
SPM segmentation tool (Fig 1q), and then ssCT images were obtained by applying a binary
whole brain mask to the original CT images (Fig 1r). Finally, the ssCT template was created by
averaging all ssCT images normalized to the MNI template space with spatial normalization
parameters for MR images (Fig 1s–1u). Detailed image processing steps for acquiring the ssCT
template were described in our previous paper [14].
For creation of the itCT template, we first transformed the intensity of native CT images
encoded with Hounsfield units into three predefined levels in order to obtain itCT images (Fig
1v) [9]. Voxel values equal to or less than -100 were linearly converted to greater values by add-
ing 1000, and those greater than 100 were converted to values greater than 3100 by adding
3000. The voxel values between -100 and 100 were linearly rescaled to a range between 900 and
3100. Thereby, most of the negative voxel values in air were eliminated, and the intensity range
representing brain tissue and CSF was increased. After the coregistration of itCT images to
inhomogeneity-corrected individual MR images (Fig 1w), itCT images were normalized to the
MNI space by applying spatial normalization parameters for MR images (Fig 1x). Finally, the
itCT template image was created by averaging all spatially normalized itCT images of 71
healthy controls (Fig 1y).
b) Creation of MR templates and ligand-specific PET template. We used two types of
MR-guided spatial normalization methods: 1) MR-guided spatial normalization with a conven-
tional spatial normalization tool in SPM8 (cvMR) and 2) MR-guided spatial normalization
with diffeomorphic anatomical registration using exponentiated lie algebra (DARTEL)
toolbox in SPM8 (dtMR) [16]. For the cvMR-guided spatial normalization, a skull-stripped
MR template image was created by averaging all skull-stripped and spatially normalized MR
images of 71 healthy controls (Fig 1f). For the dtMR-guided spatial normalization, MR images
were segmented into gray (GM) and white matter (WM), and then segmented GM/WM
images were imported to 1.5 mm isovoxel space by applying normalization parameters
obtained from the segmentation step. An initial template was created by averaging imported
GM/WM images of all controls and PD patients, and then a deformation transforming initial
template to individual subject’s GM/WMwas acquired. Inverse of this deformation was
applied to GM/WM images, and then averaged to create next template. After the iteration of
this deformation steps for six times, final GM/WM template was created.
All [18F]-FP-CIT PET images were coregistered to inhomogeneity-corrected individual MR
images and spatially normalized to MNI template space with the parameter normalizing indi-
vidual skull-stripped MR images in the conventional normalization of MR images. A ligand-
specific PET template image was created by averaging all spatially normalized PET images.
c) Spatial normalization of PET images. We obtained spatially normalized [18F]-FP-CIT
PET images using five different spatial normalization methods: cvMR-, dtMR-, ssCT-, itCT-,
and PET-guided spatial normalization. 1) For the cvMR-guided spatial normalization, the PET
images were coregistered to individual MR images and spatially normalized to the MNI space
with the parameter normalizing skull-stripped MR. 2) For the dtMR-guided spatial normaliza-
tion, the PET images coregistered to the MR images were spatially normalized to the MNI
space by applying the subject-specific DARTEL flow fields. 3) For the ssCT- guided spatial nor-
malization, ssCT images were obtained by scalp-stripping and segmentation of CT images, and
then individual PET images were spatially normalized with the parameter normalizing individ-
ual ssCT images to the ssCT template (Fig 1n–1r and 1z). 4) For the itCT-guided spatial nor-
malization, the PET images were spatially normalized with the parameter normalizing
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individual itCT images to the itCT template (Fig 1v and 1z). 5) For the PET-guided spatial nor-
malization, individual PET images were directly spatially normalized to the ligand-specific
PET template.
d) Creation of subject-specific volume of interest (VOI). We used subject-specific stria-
tal VOIs derived from FreeSurfer 5.1 (Massachusetts General Hospital, Harvard Medical
School; http://surfer.nmr.mgh.harvard.edu) as a gold standard for comparing striatal [18F]-
FP-CIT binding values derived from five different spatial normalization methods.
T1-weighted MR images were resliced to 1 mm isovoxel space, corrected for inhomogeneity,
skull-stripped, and segmented into gray and white matter. And then, subcortical structures
were segmented and labelled by a probabilistic registration technique [17]. We chose five
segmented subcortical segments of the caudate and putamen for each side, as well as that of
the cerebellum. These subcortical segments were coregistered to original PET images by
using the parameter coregistering inhomogeneity-corrected MR images created by FreeSur-
fer to CT images in native space, and finally, FreeSurfer-generated specific VOIs (FSVOI) for
the caudate, putamen and cerebellum were created. For the striatal subregional analysis, a
striatal subregional VOI template was non-linearly transformed to FSVOI by applying the
inverse of the normalization parameter transforming the MR images to the MR template
[18, 19]. Thereby, FSVOI was further parcellated into five striatal subregions (anterior and
posterior caudate, anterior and posterior putamen, and ventral striatum).
e) Creation of VOI templates. To measure striatal and cerebellar binding values in spa-
tially normalized PET images, we created VOI templates for the caudate, putamen, and cerebel-
lum. The striatal and cerebellar segments obtained from subcortical parcellation by FreeSurfer
were spatially normalized to the skull-stripped MR template within 1 mm sized isovoxel space.
Normalized segments of each region were binarized, and the probabilistic maps for each region
were created by averaging binary segments of all 71 healthy controls. We chose threshold 0.8 to
create masks for each region, and finally created a VOI template within the 2 mm sized isovoxel
space corresponding to the conventional MNI template. For the striatal subregional analysis,
we parcellated the striatal VOI template into five striatal subregions.
Estimation of standardized uptake value ratio (SUVR)
Using the VOI template, we measured regional SUV values of the cerebellum and each side of the
caudate and putamen in the PET images spatially normalized in five different methods. Regional
SUV values measured by using subject-specific FSVOI were considered to be a gold standard.
Mean SUVR values of both sides of the caudate and putamen were calculated as follows:
SUVRtarget¼ SUVtarget = SUVcerebellum
Statistical analysis
We used Prism 5 (GraphPad Software, Inc., La Jolla, CA, USA) for the statistical analyses, and
performed linear regression analysis between the SUVR values measured with specific FSVOI
on original PET images and the VOI template on the PET images spatially normalized by each
normalization method. Also, we checked the correlation between the striatal SUVR values and
the clinical severity of PD. Independent t-test was used for the group comparison and the
receiver-operator characteristic (ROC) curve analysis was used for the assessment of disease
discrimination ability of these different methods. For each spatial normalization method, we
also compared SUVR images between the healthy controls and PD patients using the voxel-
based independent t-test of SPM8.
CT-Guided Spatial Normalization of Dopamine Transporter PET
PLOSONE | DOI:10.1371/journal.pone.0132585 July 6, 2015 6 / 18
Results
All structure-guided spatial normalization methods (cvMR-, dtMR-, ssCT- and itCT-guided
methods) were similarly effective for normalizing [18F]-FP-CIT PET images of healthy controls
and PD patients in visual inspection of the spatially normalized images. However, in contrast
to appropriate spatial normalization results achieved by the PET-guided method in healthy
controls, in PD patients showing markedly reduced [18F]-FP-CIT uptake in the posterior puta-
men, PET-guided spatial normalization erroneously stretched remaining anterior putamen to
fill the defective posterior putamen (Fig 2).
Using subject-specific striatal FSVOIs, we measured SUVR values of the caudate (mean
SUVR in HC = 7.2 ± 1.4 and that in PD = 5.2 ± 1.5) and putamen (mean SUVR in
HC = 8.9 ± 1.3 and that in PD = 4.6 ± 1.1) for the comparison with those measured with striatal
template VOIs overlaid on the PET images normalized by five different spatial normalization
methods (Table 1). Although there were highly significant differences in caudate and putam-
inal SUVR values between the controls and PD patients (P< 10-4 for caudate, P< 10-22 for
putamen), there was greater range of overlapping SUVR values derived from the PET-guided
method between the two diagnostic groups (Fig 3). The cvMR-, dtMR-, ssCT-, and itCT-
guided methods resulted in overestimation of caudate SUVR values by 8.5 to 17.6%, compared
to those measured by FSVOI. For the putamen, the bias was much smaller for those four struc-
ture-guided methods (-1.9 to 9.0%). The biases of SUVR values derived from the PET-guided
method were almost similar to those derived from structure-guided methods in the controls
(caudate: 10.8%, putamen: 0.8%), but markedly greater in PD patients (caudate: 33.5%, puta-
men: 33.4%). These overestimation biases of the PET-guided method in PD patients were
greater in the regions contralateral to the clinically worse side than in the regions contralateral
to the clinically better side, most prominent in the anterior putamen (57.6%) and lowest in the
ventral striatum (17.1%) (Table 1).
The ROC curve analysis of these SUVR values for the assessment of the discrimination abil-
ity between two diagnostic groups showed that putaminal SUVR values derived from all four
Fig 2. Examples of spatial normalization by five different spatial normalization methods in a healthy control and a PD patient. Four structure-guided
spatial normalization methods work well for normalization of PET images, and the PET-guided method also works well in healthy control. However, in PD
patient the PET-guided method stretches anterior putamen posteriorly to fill the posterior putamen during the non-linear spatial normalization. Color bars are
scaled in standardized uptake value ratio (SUVR). Abbreviations: cvMR =MR-guided spatial normalization with conventional normalization tool, dtMR = MR-
guided spatial normalization with DARTEL toolbox, ssCT = skull-stripped CT-guided spatial normalization, itCT = intensity transformed CT-guided spatial
normalization, PET = PET-guided spatial normalization.
doi:10.1371/journal.pone.0132585.g002
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Table 1. Striatal SUVR values of healthy controls (HC) and Parkinson’s disease (PD) patients.
FSVOI cvMR dtMR ssCT itCT PT
mean ± SD mean ± SD bias mean ± SD bias mean ± SD bias mean ± SD bias mean ± SD bias
Caudate
HC both 7.2 ± 1.4 7.8 ± 1.1 8.5 7.9 ± 1.2 9.6 8.2 ± 1.4 14.3 8.0 ± 1.6 10.5 8.0 ± 1.0 10.8
PD both 5.2 ± 1.5 6.0 ± 1.5 15.2 6.1 ± 1.5 17.6 6.0 ± 1.6 15.0 5.8 ± 1.8 12.3 6.9 ± 1.6 33.5
worse 5.0 ± 1.6 5.8 ± 1.4 16.3 5.9 ± 1.5 19.6 5.8 ± 1.6 16.8 5.6 ± 1.8 12.9 6.7 ± 1.6 36.2
better 5.4 ± 1.6 6.2 ± 1.6 14.6 6.3 ± 1.6 16.1 6.1 ± 1.8 13.5 6.0 ± 2.0 12.1 7.1 ± 1.6 31.3
Anterior caudate
HC both 7.9 ± 1.5 8.3 ± 1.3 4.8 8.5 ± 1.3 8.2 8.8 ± 1.6 11.8 8.5 ± 1.8 7.9 8.5 ± 1.2 7.5
PD both 5.7 ± 1.8 6.3 ± 1.6 10.7 6.6 ± 1.7 16.4 6.3 ± 1.8 11.7 6.2 ± 2.0 9.8 7.4 ± 1.8 30.5
worse 5.4 ± 1.8 6.0 ± 1.6 11.6 6.4 ± 1.7 18.4 6.1 ± 1.8 13.7 6.0 ± 2.0 10.6 7.2 ± 1.8 33.8
better 5.9 ± 1.8 6.5 ± 1.7 10.3 6.8 ± 1.7 15.1 6.5 ± 2.0 10.4 6.5 ± 2.2 9.6 7.6 ± 1.8 28.0
Posterior caudate
HC both 5.5 ± 1.4 5.6 ± 0.9 1.3 4.7 ± 1.1 -15.1 6.2 ± 1.3 13.1 5.8 ± 1.6 5.2 5.5 ± 0.7 -0.7
PD both 3.8 ± 1.1 4.3 ± 1.1 14.2 3.3 ± 0.9 -12.0 4.5 ± 1.3 18.9 4.0 ± 1.6 6.4 5.0 ± 1.3 31.1
worse 3.5 ± 1.2 4.2 ± 1.0 19.6 3.3 ± 0.9 -7.5 4.4 ± 1.3 25.3 3.8 ± 1.7 8.1 4.8 ± 1.4 34.9
better 3.9 ± 1.3 4.5 ± 1.2 13.6 3.4 ± 1.0 -12.8 4.6 ± 1.4 17.2 4.2 ± 1.7 7.2 5.1 ± 1.3 30.2
Putamen
HC both 8.9 ± 1.3 8.8 ± 1.2 -1.9 9.0 ± 1.2 0.6 8.9 ± 1.3 -0.5 9.1 ± 1.3 2.1 9.0 ± 1.0 0.8
PD both 4.6 ± 1.1 4.7 ± 1.0 2.3 4.9 ± 1.0 7.0 4.7 ± 1.1 2.3 5.0 ± 1.1 9.0 6.1 ± 1.4 33.4
worse 4.2 ± 1.0 4.2 ± 0.9 1.1 4.4 ± 0.9 5.7 4.3 ± 1.0 2.4 4.6 ± 1.0 10.7 5.9 ± 1.4 40.3
better 4.9 ± 1.4 5.1 ± 1.2 3.0 5.3 ± 1.2 7.6 5.0 ± 1.4 1.9 5.3 ± 1.4 7.2 6.3 ± 1.4 27.1
Anterior putamen
HC both 9.2 ± 1.4 10.1 ± 1.4 9.4 10.2 ± 1.4 10.7 10.0 ± 1.5 8.6 10.1 ± 1.4 9.0 10.4 ± 1.2 12.1
PD both 4.6 ± 1.3 5.2 ± 1.4 13.5 5.4 ± 1.4 18.1 5.1 ± 1.5 12.3 5.6 ± 1.5 23.1 7.2 ± 1.8 57.6
worse 4.1 ± 1.2 4.6 ± 1.2 12.5 4.8 ± 1.3 17.3 4.7 ± 1.4 13.2 5.2 ± 1.4 25.9 7.0 ± 1.8 68.9
better 5.0 ± 1.7 5.8 ± 1.7 14.8 6.0 ± 1.7 19.3 5.6 ± 2.0 12.0 6.1 ± 1.9 21.3 7.5 ± 1.9 48.8
Posterior putamen
HC both 8.9 ± 1.4 8.6 ± 1.2 -3.7 8.8 ± 1.3 -1.5 8.7 ± 1.5 -3.0 9.1 ± 1.5 2.0 9.0 ± 1.1 0.3
PD both 3.4 ± 0.9 3.5 ± 0.8 5.0 3.7 ± 0.9 10.5 3.6 ± 1.0 5.7 3.8 ± 0.9 12.2 4.9 ± 1.3 46.4
worse 3.0 ± 1.0 3.2 ± 0.8 5.4 3.3 ± 0.9 10.0 3.2 ± 0.9 7.0 3.4 ± 0.9 14.8 4.8 ± 1.3 59.9
better 3.8 ± 1.2 3.9 ± 1.1 3.6 4.2 ± 1.1 9.8 3.9 ± 1.3 3.6 4.1 ± 1.1 8.8 5.1 ± 1.3 34.2
Ventral striatum
HC both 8.5 ± 1.1 8.0 ± 1.0 -5.7 8.4 ± 1.0 -1.5 8.2 ± 1.1 -3.3 8.3 ± 1.3 -2.3 8.1 ± 0.8 -4.4
PD both 5.9 ± 1.5 6.2 ± 1.3 4.0 6.5 ± 1.4 9.4 6.0 ± 1.4 1.9 6.2 ± 1.5 5.0 6.9 ± 1.4 17.1
worse 5.7 ± 1.4 5.9 ± 1.3 3.2 6.2 ± 1.3 9.5 5.8 ± 1.4 2.2 6.1 ± 1.5 6.5 6.7 ± 1.4 18.7
better 6.2 ± 1.6 6.4 ± 1.5 4.2 6.7 ± 1.5 8.9 6.2 ± 1.6 1.1 6.4 ± 1.6 3.2 7.1 ± 1.4 15.1
Biases were calculated as the % difference between the SUVR values derived from each spatial normalization method and those measured with FSVOI.
For PD patients, data are presented with the SUVR values of combined region of both sides (both), those of the regions contralateral to the clinically
worse side (worse), and those of the regions contralateral to the clinically better side (better). Abbreviations: FSVOI = FreeSurfer-generated volume of
interest, cvMR = MR-guided spatial normalization with conventional tool, dtMR = MR-guided spatial normalization with DARTEL toolbox, ssCT = skull-
stripped CT-guided spatial normalization, itCT = intensity transformed CT-guided spatial normalization, PET = PET-guided spatial normalization
doi:10.1371/journal.pone.0132585.t001
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structure-guided spatial normalization methods were highly effective for discriminating PD
patients from controls (Fig 4). However, although the PET-guided spatial normalization
method was also effective, the area under the ROC curve (AUC) value was lowest among the
five spatial normalization methods. In contrast to very small difference in posterior putaminal
AUC values between the PET- and the other four structure-guided spatial normalization
Fig 3. Striatal standardized uptake value ratio (SUVR) values (A: caudate, B: putamen) of healthy
controls (HC) and Parkinson’s disease (PD) patients. The horizontal red bars represent mean and
standard deviation (SD). T- and P-values for comparing two groups with independent t-test are presented on
the top of the graphs. Abbreviations: FSVOI = FreeSurfer-generated volume of interest, cvMR =MR-guided
spatial normalization with conventional normalization tool, dtMR = MR-guided spatial normalization with
DARTEL toolbox, ssCT = skull-stripped CT-guided spatial normalization, itCT = intensity transformed CT-
guided spatial normalization, PET = PET-guided spatial normalization.
doi:10.1371/journal.pone.0132585.g003
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methods (Fig 4D), the difference in AUC values for the anterior putamen were greater than
that for the posterior putamen (Fig 4C).
Similarly, in PD and control subjects combined, SUVR values derived from all four struc-
ture-guided methods well correlated with those measured with FSVOI (P< 0.0001; R2 for
caudate> 0.84, R2 for putamen> 0.94). However, the PET-guided method excessively overes-
timated striatal SUVR values in the PD patients, and thereby spoiled the linearity between the
striatal SUVR values in all subjects (Fig 5A and 5B). The striatal regional SUVR values derived
from all four structure-guided spatial normalization methods correlated well with those
Fig 4. Receiver-operator characteristic (ROC) curve analysis of striatal SUVR values derived from five different spatial normalization methods for
the separation of controls and Parkinson’s disease (PD) patients. The area under the curve (AUC) values are presented in the right lower corner of each
graph. Putaminal SUVR values derived from all five spatial normalization methods very effectively discriminated PD patients. Both CT-guided methods show
similar performance to both MR-guided methods. However, the PET-guided method was less effective than the other four structure-guided spatial
normalization methods. Abbreviations: cvMR =MR-guided spatial normalization with conventional normalization tool, dtMR = MR-guided spatial
normalization with DARTEL toolbox, ssCT = skull-stripped CT-guided spatial normalization, itCT = intensity transformed CT-guided spatial normalization,
PET = PET-guided spatial normalization.
doi:10.1371/journal.pone.0132585.g004
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Fig 5. Regression analysis between the standardized uptake value ratio (SUVR) valuesmeasuredwith individual volume of interest (FSVOI) and
those derived from five different spatial normalizationmethods (A and B), and correlation between the regional SUVR values and the clinical severity
scores (C and D). In A and B, regression lines for each diagnostic group are presented with green (healthy controls; HC) and red (Parkinson’s disease; PD)
dotted lines. Closed (HC) and open (PD) circles represent regional SUVR values of individual subjects. The R2 values for regression analysis in all subjects are
presented in the right lower corner of each graph. The PET-guided spatial normalization method excessively overestimates striatal SUVR values in PD patients,
and results in higher discrepancy in the regression line between the controls and PD patients. In C and D, closed circles represent individual striatal SUVR
values and the red lines represent regression lines. The SUVR values derived from all five spatial normalization methods are correlated with clinical severity of
PD, but the statistical power is lowest for the PET-guided method. Abbreviations: FSVOI = FreeSurfer-generated volume of interest, cvMR =MR-guided spatial
normalization with conventional normalization tool, dtMR =MR-guided spatial normalization with DARTEL toolbox, ssCT = skull-stripped CT-guided spatial
normalization, itCT = intensity transformed CT-guided spatial normalization, PET = PET-guided spatial normalization.
doi:10.1371/journal.pone.0132585.g005
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measured by subregional FSVOI. However, except ventral striatum in which binding is rela-
tively preserved, the correlation between the subregional SUVR values derived from the PET-
guided method and those measured by subregional FSVOI was the lowest (S3 Fig).
The caudate and putaminal SUVR values derived from the five normalization methods were
correlated with clinical severity measured with UPDRS motor score in PD patients. However,
the statistical significance for the PET-guided method was lowest among the five methods (cau-
date: R2 = 0.07, P = 0.042 and putamen: R2 = 0.12, P = 0.01) (Fig 5C and 5D). Although two
CT-guided spatial normalization methods (ssCT- and itCT-guided) showed almost similar
results for the correlation with the SUVR values measured with FSVOI (ssCT: caudate R2 =
0.92, putamen R2 = 0.95 vs. itCT: caudate R2 = 0.84, putamen R2 = 0.94) and with clinical sever-
ity (ssCT: caudate R2 = 0.11, putamen R2 = 0.22 vs. itCT: caudate R2 = 0.11, putamen R2 =
0.19), the ssCT-guided method showed slightly better correlations (Fig 5) as well as group dif-
ferences and discrimination (Figs 3 and 4).
Mean SUVR images of the control subjects were similar across different spatial normaliza-
tion methods. However, the mean SUVR image of the PET-guided method showed erroneous
overestimation of the caudate and anterior putaminal uptake and lower contrast of asymmetry
of putaminal uptake. Standard deviation (SD) images of dtMR- and PET-guided method in
control subjects showed very low and rather homogeneous SD values in the entire striatum,
whereas the SD images of the cvMR-guided and the two CT-guided methods showed higher SD
values around the striatal border, suggesting greater spatial variability. As expected, the voxel-
based comparison between the controls and PD patients showed the greatest differences in
dtMR- and cvMR-guided methods (family-wise error corrected P< 0.001). Two CT-guided
methods also showed highly significant differences across the entire putamen. Nevertheless, the
level of significance for the anterior putamen was lowest for the PET-guided method (Fig 6).
Discussion
This study found that two CT-guided spatial normalization methods are effective for the analy-
sis of [18F]-FP-CIT PET images and almost comparable to the MR-guided methods in showing
striatal dopaminergic deficit, in discriminating PD patients from controls, and in reflecting dis-
ease severity. Compared to the itCT-guided method, the striatal SUVR values derived from the
ssCT-guided method showed slightly better correlation with those measured by FSVOI and
with clinical severity measured by UPDRS motor score. The PET-guided method was not suit-
able for normalization of [18F]-FP-CIT PET images, because of its serious overestimation bias
of striatal SUVR in PD patients.
Spatial normalization is crucial for unbiased template VOI-based or voxel-based analysis of
PET images. Ligand-specific PET template-guided spatial normalization is easy to apply and
has been used for various radioligands [2, 8, 20, 21]. Unlike the radioligands binding to the
receptors distributed in widespread brain, the radioligands for dopamine transporter avidly
bind to some restricted areas (e.g. striatum), and thus, spatial normalization is driven mainly
by the striatum. The ligand-specific template for [11C]-raclopride PET, which shows similar
binding pattern like dopamine transporter PET in healthy controls, works for spatial normali-
zation and even better than the MR-guided method [2, 20]. In contrast, regional selectivity of
nigral neuronal death in PD patients leads to selective loss of dopamine transporter binding to
posterior putamen in dopamine transporter PET [4, 22]. Lack of dopamine transporter binding
in the posterior putamen without structural loss and relative preservation of binding in the cau-
date and anterior putamen leads to spatial normalization error stretching the anterior putamen
posteriorly and filling missing posterior putamen. Thereby, striatal binding can be extremely
overestimated in PD patients compared to healthy controls as shown in this study. Striatal
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Fig 6. Mean and standard deviation (SD) images of each spatial normalization method and the results
of voxel-based comparison between the healthy controls (HC) and Parkinson’s disease (PD) patients.
For PD patients images were flipped to locate more affected side (contralateral to the clinically worse side; W)
on the left (L) and the less affected side (contralateral to the clinically better side; B) on the right (R). The
mean images of controls and PD patients derived from four structure-guided spatial normalization methods
are similar. However, the caudate and anterior part of the putamen of PD patients were overestimated, and
thereby, the mean image of PD patients derived from the PET-guided method shows higher uptake and in
those regions. In contrast to the tendency shown in the mean images, the SD images of two CT-guided
methods show higher SD values around the striatum, suggesting higher spatial variability. Voxel-based
comparison between the controls and PD patients (family-wise error corrected) show the highest significance
with the dtMR-guided method, and two CT-guided methods were inferior to the MR-guided methods. Color
bars for mean and SD images represent standardized uptake value ratio (SUVR), and that for the voxel-
based comparison images represents T-value for the comparison. Abbreviations: cvMR =MR-guided spatial
normalization with conventional normalization tool, dtMR = MR-guided spatial normalization with DARTEL
toolbox, ssCT = skull-stripped CT-guided spatial normalization, itCT = intensity transformed CT-guided
spatial normalization, PET = PET-guided spatial normalization.
doi:10.1371/journal.pone.0132585.g006
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binding derived from PET-guided method may be less reflective of real striatal dopaminergic
deficit and clinical severity. Nevertheless, ligand-specific template for presynaptic dopaminer-
gic nerve terminal imaging had been used in several clinical studies without proper validation
[19, 23, 24]. One study showed the feasibility of ligand-specific [18F]-FP-CIT PET template
and good correlation between the striatal binding and clinical severity scores [25]. Since only
the PD patients were analyzed, they might have missed the unbalanced overestimation of stria-
tal binding between the PD patients and controls. To overcome this problem, summed image
of entire time frames of dynamic PET, which represents delivery and specific binding of a radi-
oligand [6], or perfusion-like PET derived from early time frames of dynamic PET can be used
for the acquisition of spatial normalization parameter [2, 5, 26]. However, as longer scan time
for the dynamic PET is necessary to get the summed image or early phase perfusion-like PET,
it may not be suitable for routine clinical use.
MR images that provide structural information can increase the accuracy of spatial normali-
zation of PET without being affected by the binding pattern of radioligands [7, 8], and this
MR-guided method has been used by many clinical studies of PET. The accuracy can be more
increased by removal of the skull and surrounding non-brain tissue [11–13], or by applying a
deformation flow field acquired from different tissue types separately like DARTEL [16]. Struc-
tural images can also be provided by CT scanner although its resolution is much lower than the
MR imaging. As the native CT images are inappropriate for spatial normalization, due to great
differences in intensity between the skull and brain tissue, Rorden and colleagues developed a
CT-guided spatial normalization method with intensity transformed CT image (itCT-guided
method) [9]. They artificially modified intensity to increase the intensity range for brain tissue
and to reduce the intensity of the skull. Another approach for CT-guided spatial normalization
utilizes a skull-stripped CT [10]. They used Brain Extraction Tool (BET) for skull-stripping of
CT image, but it is difficult to obtain optimal result with BET. We recently developed a sophis-
ticated method for skull-stripping of CT image with SPM segmentation toolbox and created
skull-stripped CT template for ssCT-guided spatial normalization [14]. As we expected, this
ssCT-guided spatial normalization method for [18F]-FP-CIT PET showed almost the same
result as the MR-guided methods for acquiring striatal SUVR values. Although there was no
large difference between the performances of the ssCT- and itCT-guided methods, the ssCT-
guided method showed slightly better correlation with the SUVR values measured with FSVOI
(P< 0.05, Fisher’s r to z transformation) and with clinical severity scores.
Although our proposed ssCT-guided method can be a reliable and objective method for
measuring striatal and even smaller subregional SUVR for [18F]-FP-CIT PET, the image pro-
cessing steps are complicated and requires longer computing time [cvMR: 10 min, ssCT: 15–30
min, itCT:< 1 min, and PET:< 1min for single subject processing in Mac Pro early 2008
model (Apple Inc., Cupertino, CA) with a dual 3.2GHz quad core Xeon CPU and 16 GB mem-
ory]. The itCT-guided method has an advantage over the ssCT-guided method in that it is sim-
pler and requires less computing time, although it was slightly less effective than the ssCT-
guided method. Therefore, one of these CT-guided spatial normalization methods can be cho-
sen, at least, for the analysis of [18F]-FP-CIT PET.
Internal subcortical gray matter structures cannot be visualized clearly in the CT images as
the resolution of CT images is much lower than that of MR images. Therefore, it is clear that
the MR-guided methods are best for the analysis of these subcortical structures and these CT-
guided methods are alternatives, although we showed feasibility of these CT-guided methods
in VOI-based analysis. This might have caused greater variability around the striatal border in
the SD images derived from CT-guided methods (Fig 6).
Although we visually checked coregistration quality, another drawback common for the
structure-guided methods is the possible misalignment in the coregistration step between the
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PET and structural images because of the very low uptake of [18F]-FP-CIT in the brain tissue
surrounding the striatum. We neglected head motion during the acquisition of PET and did
not coregistered PET to CT images due to short scan time. However, still there might be a pos-
sible head motion during this short scan time, and this may raise concern of bias in the SUVR
values.
The advantage of these CT-guided spatial normalization methods for PET imaging is that
they do not require additional structural images from a different scanner, because the PET/
CT scanners typically provide structural CT images. Although the MR-guided methods are
more accurate and the best for obtaining structural information, the CT-guided methods
may be also useful when MR imaging is contraindicated due to an implanted cardiac pace-
maker or claustrophobia and when a dynamic PET scan providing early phase perfusion-like
PET images is unavailable. In addition, these methods may be useful for the PET imaging
with various radioligands of which binding is limited to some regions of the brain or of
which binding pattern is quite different between the controls and patients (e.g. [11C]-PIB).
Future studies will be needed to validate these CT-guided methods for extension of these
techniques to other types of radioligands.
Conclusions
CT-guided spatial normalization methods provide reliable striatal SUVR values almost compa-
rable to those obtained with MR-guided methods and can be useful for analyzing dopamine
transporter PET images when structural MR images are unavailable.
Supporting Information
S1 Fig. Regression analysis between the SUVR values measured with individual volume of
interest (FSVOI) and those derived from five different spatial normalization methods.
Regression lines for each diagnostic group are presented with green (healthy controls; HC) and
red (Parkinson’s disease; PD) dotted lines. Closed (HC) and open (PD) circles represent
regional SUVR values of individual subjects. Regional SUVR values of control subjects were
calculated as the mean of both sides. For PD patients the SUVR values were measured with the
regional VOI contralateral to the clinically worse side (worse) and contralateral to the clinically
better side (better). The R2 values for regression analysis in all subjects are presented in the
right lower corner of each graph. The PET-guided spatial normalization method excessively
overestimates striatal SUVR values in PD patients, and results in higher discrepancy in regres-
sion lines between the controls and PD patients.
(TIF)
S2 Fig. Receiver-operator characteristic (ROC) curve analysis of striatal SUVR values
derived from five different spatial normalization methods for the separation of controls
and Parkinson’s disease (PD) patients. Data of the regions contralateral to the clinically
worse (more affected side) and better sides (less affected side) were analyzed separately. The
area under the curve (AUC) values are presented in the right lower corner of each graph.
Putaminal SUVR values derived from all five spatial normalization methods very effectively
discriminated PD patients, and those of the more affected side perform better than those of less
affected side. Both CT-guided methods show similar performance to both MR-guided meth-
ods. However, the PET-guided method was less effective than the other four structure-guided
spatial normalization methods.
(TIF)
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S3 Fig. Regression analysis between the striatal subregional SUVR values measured with
individual volume of interest (FSVOI) and those derived from five different spatial normal-
ization methods. Regression lines for each diagnostic group are presented with green (healthy
controls; HC) and red (Parkinson’s disesase; PD) dotted lines. Closed (HC) and open (PD) cir-
cles represent regional SUVR values of individual subjects. Regional SUVR values of control
subjects were calculated as the mean of both sides. For PD patients the SUVR values were mea-
sured with the regional VOI contralateral to the clinically worse side (worse) and contralateral
to the clinically better side (better). The R2 values for regression analysis in all subjects are pre-
sented in the right lower corner of each graph. Although both MR-guided spatial normalization
methods performed best for providing reliable subregional SUVR values, both CT-guided
methods also worked almost similar to the cvMR-guided method. However, the PET-guided
spatial normalization method excessively overestimated striatal SUVR values in PD patients,
and resulted in higher discrepancy in regression lines between the controls and PD patients.
This overestimation bias of the PET-guided method was most pronounced in the anterior
putamen and the regions contralateral to the clinically more affected side.
(TIF)
S1 File. Demographic data for the included subjects, raw data for the regional and subre-
gional SUV and SUVR values, and the graphs created in this study.
(ZIP)
S1 Table. SUV values of striatal regions and cerebellum. Biases were calculated as the % dif-
ference between the SUV values derived from each spatial normalization method and those
measured with FSVOI. For PD patients data are presented with the SUV values of combined
region of both sides (both), those of the region contralateral to the clinically worse side (worse),
and those of the region contralateral to the clinically better side (better). Abbreviations:
FSVOI = FreeSurfer-generated volume of interest, cvMR =MR-guided spatial normalization
with conventional tool, dtMR =MR-guided spatial normalization with DARTEL toolbox,
ssCT = skull-stripped CT-guided spatial normalization, itCT = intensity transformed CT-
guided spatial normalization, PET = PET-guided spatial normalization.
(DOC)
S2 Table. Statistical comparison between the SUVR values derived from each spatial nor-
malization method and those measured with FSVOI. The statistical significance of indepen-
dent t-test between the SUVR values derived from each spatial normalization method and
those measured with FSVOI are presented with P-values for each comparison. For PD patients
P-values are presented with those of combined region of both sides (both), those of the region
contralateral to the clinically worse side (worse), and those of the region contralateral to the
clinically better side (better). Abbreviations: FSVOI = FreeSurfer-generated volume of interest,
cvMR =MR-guided spatial normalization with conventional tool, dtMR =MR-guided spatial
normalization with DARTEL toolbox, ssCT = skull-stripped CT-guided spatial normalization,
itCT = intensity transformed CT-guided spatial normalization, PET = PET-guided spatial nor-
malization, n.s. = not significant.
(DOC)
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